Transdermal therapeutic systems for the administration of...

Details Transdermal therapeutic systems for the administration of... Transdermal therapeutic systems for the administration of...

A - Human Necessities

61

K

167/231

A61K 9/70 (2006.01) A61K 31/485 (2006.01) A61K 47/14 (2006.01)

Patent

CA 1255229

ABSTRACT OF THE DISCLOSURE A method for transdermal delivery of naloxone, naltrexone and nalbuphine base through intact skin is described. Preferred embodiments of transdermal therapeutic systems for delivering these drugs and polyethylene glycol monolaurate employ an ethylene vinylacetate matrix containing drug base at a concentration above saturation and polyethylene glycol monolaurate below unit activity. Polyethylene glycol manolaurate is disclosed as a permeation enhancer for the base form of these drugs and is preferably delivered simultaneously with the drug.

492483

Affiliated with

Also associated with

Rating

Transdermal therapeutic systems for the administration of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal therapeutic systems for the administration of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal therapeutic systems for the administration of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1266338